Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Falkenhorst

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
BMC Public Health|November 2, 2012
Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in GermanyMerle M Böhmer, Dietmar Walter, Gerhard Falkenhorst, et al.
Vaccine|July 10, 2012
Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in childrenMark van der Linden, Susanne Weiß, Gerhard Falkenhorst, et al.
Vaccine|December 21, 2017
Invasive pneumococcal disease in children under 16 years of age: Incomplete rebound in incidence after the maximum effect of PCV13 in 2012/13 in GermanyRaphael Weinberger, Rüdiger von Kries, Mark van der Linden, et al.
Vaccine|November 5, 2015
Incidence of invasive pneumococcal disease in 5-15 year old children with and without comorbidities in Germany after the introduction of PCV13: Implications for vaccinating children with comorbiditiesRaphael Weinberger, Gerhard Falkenhorst, Christian Bogdan, et al.
Diagnostic Microbiology and Infectious Disease|July 17, 2012
Detection of antibodies to Campylobacter in humans using enzyme-linked immunosorbent assays: a review of the literatureKatrin Gaardbo Kuhn, Gerhard Falkenhorst, Tina Ceper, et al.
Human Vaccines & Immunotherapeutics|December 4, 2015
Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in GermanyCarrie L Anderson, Cornelius Remschmidt, Frank-Peter Drobnitzky, et al.
BMC Infectious Diseases|June 2, 2012
Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controlsWiebke Hellenbrand, Pernille Jorgensen, Brunhilde Schweiger, et al.
Epidemiology and Infection|January 14, 2024
Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study)Bettina M Rosner, Gerhard Falkenhorst, Isabella Kumpf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2014
Seroincidence of human infections with nontyphoid Salmonella compared with data from public health surveillance and food animals in 13 European countriesKåre Mølbak, Jacob Simonsen, Charlotte S Jørgensen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 16, 2010
Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventionsJesús de Pedro-Cuesta, Ignacio Mahillo-Fernández, Alberto Rábano, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
BMC Public Health|November 2, 2012
Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in GermanyMerle M Böhmer, Dietmar Walter, Gerhard Falkenhorst, et al.
Vaccine|July 10, 2012
Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in childrenMark van der Linden, Susanne Weiß, Gerhard Falkenhorst, et al.
Vaccine|December 21, 2017
Invasive pneumococcal disease in children under 16 years of age: Incomplete rebound in incidence after the maximum effect of PCV13 in 2012/13 in GermanyRaphael Weinberger, Rüdiger von Kries, Mark van der Linden, et al.
Vaccine|November 5, 2015
Incidence of invasive pneumococcal disease in 5-15 year old children with and without comorbidities in Germany after the introduction of PCV13: Implications for vaccinating children with comorbiditiesRaphael Weinberger, Gerhard Falkenhorst, Christian Bogdan, et al.
Diagnostic Microbiology and Infectious Disease|July 17, 2012
Detection of antibodies to Campylobacter in humans using enzyme-linked immunosorbent assays: a review of the literatureKatrin Gaardbo Kuhn, Gerhard Falkenhorst, Tina Ceper, et al.
Human Vaccines & Immunotherapeutics|December 4, 2015
Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in GermanyCarrie L Anderson, Cornelius Remschmidt, Frank-Peter Drobnitzky, et al.
BMC Infectious Diseases|June 2, 2012
Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controlsWiebke Hellenbrand, Pernille Jorgensen, Brunhilde Schweiger, et al.
Epidemiology and Infection|January 14, 2024
Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study)Bettina M Rosner, Gerhard Falkenhorst, Isabella Kumpf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2014
Seroincidence of human infections with nontyphoid Salmonella compared with data from public health surveillance and food animals in 13 European countriesKåre Mølbak, Jacob Simonsen, Charlotte S Jørgensen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 16, 2010
Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventionsJesús de Pedro-Cuesta, Ignacio Mahillo-Fernández, Alberto Rábano, et al.
Pageof 4